{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:38:57Z","timestamp":1791952737759,"version":"4.3.4"},"reference-count":34,"publisher":"Scientific Scholar","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Nephrol"],"published-print":{"date-parts":[[2018]]},"DOI":"10.4103\/ijn.ijn_207_17","type":"journal-article","created":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T09:28:02Z","timestamp":1530782882000},"page":"351","source":"Crossref","is-referenced-by-count":9,"title":["Efficacy and cost comparison of ertapenem as outpatient parenteral antimicrobial therapy in acute pyelonephritis due to extended-spectrum beta-lactamase-producing Enterobacteriaceae"],"prefix":"10.25259","volume":"28","author":[{"given":"S","family":"Puthran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Ramasubramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Murlidharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Nambi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Pavithra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Petigara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"key-10.4103\/0971-4065.236048-1","first-page":"55","volume-title":"Current status in outpatient parenteral antimicrobial therapy: A practical view","author":"Candel","year":"2016","journal-title":"Rev Esp Quimioter"},{"key":"key-10.4103\/0971-4065.236048-2","first-page":"7","volume-title":"Outcomes from global adult outpatient parenteral antimicrobial therapy programmes: A review of the last decade","author":"MacKenzie","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"key-10.4103\/0971-4065.236048-3","first-page":"1","volume-title":"Optimization of a model of out-of-hospital antibiotic therapy (OPAT) in a Belgian university hospital resulting in a proposal for national implementation","author":"Ravelingien","year":"2016","journal-title":"Acta Clin Belg"},{"key":"key-10.4103\/0971-4065.236048-4","first-page":"1651","volume-title":"Practice guidelines for outpatient parenteral antimicrobial therapy.IDSA guidelines","author":"Tice","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/0971-4065.236048-5","first-page":"307","volume-title":"The history and evolution of outpatient parenteral antibiotic therapy (OPAT)","author":"Williams","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"key-10.4103\/0971-4065.236048-6","first-page":"965","volume-title":"Outpatient parenteral antimicrobial therapy and antimicrobial stewardship: Challenges and checklists","author":"Gilchrist","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/0971-4065.236048-7","first-page":"617","volume-title":"Outpatient parenteral antibiotic therapy: Principles and practice","author":"Seaton","year":"2013","journal-title":"Eur J Intern Med"},{"key":"key-10.4103\/0971-4065.236048-8","first-page":"473","volume-title":"Outpatient parenteral antibiotic therapy (OPAT) in different countries: A comparison","author":"Esposito","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"key-10.4103\/0971-4065.236048-9","first-page":"569","volume-title":"An outcomes analysis of outpatient parenteral antibiotic therapy (OPAT) in a large Asian cohort","author":"Seetoh","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"key-10.4103\/0971-4065.236048-10","first-page":"2389","volume-title":"Comparative outcomes of \u03b2-lactam antibiotics in outpatient parenteral antibiotic therapy: Treatment success, readmissions and antibiotic switches","author":"Lee","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/0971-4065.236048-11","unstructured":"BSAC OPAT. Available from: http:\/\/www.e-opat.com. [Last accessed on 2016 Jun 27]."},{"key":"key-10.4103\/0971-4065.236048-12","first-page":"39","volume-title":"A national survey of infectious disease practitioners on their use of outpatient parenteral antimicrobial therapy (OPAT)","author":"Muldoon","year":"2015","journal-title":"Infect Dis (Lond)"},{"key":"key-10.4103\/0971-4065.236048-13","first-page":"e008965","volume-title":"Community IntraVenous Antibiotic Study (CIVAS): Protocol for an evaluation of patient preferences for and cost-effectiveness of community intravenous antibiotic services","author":"Czoski","year":"2015","journal-title":"BMJ Open"},{"key":"key-10.4103\/0971-4065.236048-14","first-page":"46","volume-title":"A cost analysis of outpatient parenteral antibiotic therapy (OPAT): An Asian perspective","author":"Yong","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"key-10.4103\/0971-4065.236048-15","first-page":"S46","volume-title":"Ongoing trials of simplified antibiotic regimens for the treatment of serious infections in young infants in South Asia and Sub-Saharan Africa: Implications for policy","author":"Esamai","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.4103\/0971-4065.236048-16","first-page":"667","volume-title":"Community-based treatment of serious bacterial infections in newborns and young infants: A randomized controlled trial assessing three antibiotic regimens","author":"Zaidi","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.4103\/0971-4065.236048-17","first-page":"272","volume-title":"Outpatient parenteral antimicrobial therapy for orthopedic infections \u2013 A successful public healthcare experience in Brazil","author":"Oliveira","year":"2016","journal-title":"Braz J Infect Dis"},{"key":"key-10.4103\/0971-4065.236048-18","first-page":"25","volume-title":"Ertapenem in outpatient parenteral antimicrobial therapy for complicated urinary tract infections","author":"Trad","year":"2017","journal-title":"J Chemother"},{"key":"key-10.4103\/0971-4065.236048-19","first-page":"3437","volume-title":"Safety and efficacy of long-term outpatient ertapenem therapy","author":"Qureshi","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0971-4065.236048-20","first-page":"1510","volume-title":"Ertapenem administered as outpatient parenteral antibiotic therapy for urinary tract infections caused by extended-spectrum-beta-lactamase-producing gram-negative organisms","author":"Bazaz","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/0971-4065.236048-21","first-page":"ii83","volume-title":"Ertapenem: A new opportunity for outpatient parenteral antimicrobial therapy","author":"Tice","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/0971-4065.236048-22","first-page":"182","volume-title":"Prevalence of extended spectrum beta lactamase (ESBL) producers among gram negative bacilli from various clinical isolates in a tertiary care hospital at Jhalawar, Rajasthan, India","author":"Dalela","year":"2012","journal-title":"J Clin Diagn Res"},{"key":"key-10.4103\/0971-4065.236048-23","first-page":"417","volume-title":"An update on newer B-lactamases","author":"Gupta","year":"2007","journal-title":"Indian J Med Res","ISSN":"https:\/\/id.crossref.org\/issn\/0971-5916","issn-type":"print"},{"key":"key-10.4103\/0971-4065.236048-24","first-page":"766","volume-title":"Comparison of community-onset healthcare-associated and hospital-acquired urinary infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and antimicrobial activities","author":"Saltoglu","year":"2015","journal-title":"Int J Clin Pract"},{"key":"key-10.4103\/0971-4065.236048-25","first-page":"476","volume-title":"Comparison of ertapenem and ceftriaxone therapy for acute pyelonephritis and other complicated urinary tract infections in Korean adults: A randomized, double-blind, multicenter trial","author":"Park","year":"2012","journal-title":"J Korean Med Sci"},{"key":"key-10.4103\/0971-4065.236048-26","first-page":"ii67","volume-title":"Treatment of complicated urinary tract infection in adults: Combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy","author":"Wells","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/0971-4065.236048-27","first-page":"195","volume-title":"Ertapenem.A review of its microbiologic, pharmacokinetic and clinical aspects","author":"Cunha","year":"2002","journal-title":"Drugs Today (Barc)"},{"key":"key-10.4103\/0971-4065.236048-28","first-page":"454","volume-title":"Ertapenem","author":"Parakh","year":"2009","journal-title":"Kathmandu Univ Med J (KUMJ)"},{"key":"key-10.4103\/0971-4065.236048-29","first-page":"189","volume-title":"Coexistence of extended spectrum beta-lactamases, AMPC beta-lactamases and metallo beta-lactamases in Acinetobacter baumannii from burns patients: A Report from a Tertiary Care Center in India","author":"Gupta","year":"2013","journal-title":"Ann Burns Fire Disasters"},{"key":"key-10.4103\/0971-4065.236048-30","first-page":"2895","volume-title":"Ertapenem versus ceftriaxone followed by appropriate oral therapy for treatment of complicated urinary tract infections in adults: Results of a prospective, randomized, double-blind multicenter study","author":"Tomera","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0971-4065.236048-31","first-page":"16","volume-title":"A prospective, multicenter, randomized, double-blind study comparing ertapenem and ceftriaxone followed by appropriate oral therapy for complicated urinary tract infections in adults","author":"Jimenez-Cruz","year":"2002","journal-title":"Urology"},{"key":"key-10.4103\/0971-4065.236048-32","unstructured":"Treatment Guidelines for Antimicrobial Use in Common Syndromes. Indian Council of Medical Research. Department of Health Research. New Delhi, India; 2017."},{"key":"key-10.4103\/0971-4065.236048-33","unstructured":"Grabe M, Bartoletti R, Johansen TE, Cai T, Cek M, Koves B, et al. Guidelines on Urological Infections. European Association of Urology. Limited Update; March, 2015."},{"key":"key-10.4103\/0971-4065.236048-34","first-page":"1053","volume-title":"Good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: A consensus statement","author":"Chapman","year":"2012","journal-title":"J Antimicrob Chemother"}],"container-title":["Indian Journal of Nephrology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T19:45:11Z","timestamp":1712173511000},"score":1,"resource":{"primary":{"URL":"https:\/\/indianjnephrol.org\/efficacy-and-cost-comparison-of-ertapenem-as-outpatient-parenteral-antimicrobial-therapy-in-acute-pyelonephritis-due-to-extended-spectrum-beta-lactamase-producing-enterobacteriaceae\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"alternative-id":["236048"],"URL":"https:\/\/doi.org\/10.4103\/ijn.ijn_207_17","relation":{},"ISSN":["0971-4065"],"issn-type":[{"value":"0971-4065","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}